Supernus Pharmaceuticals, Inc.
← Back to SUPN Overview

Supernus Pharmaceuticals, Inc. (SUPN)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-173.57

Financial Fundamentals

SUPN • Quarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2009-12-31-2.27
2010-09-30—
2010-12-31-2.17
2011-03-31-1.68
2011-06-30-2.52
2011-09-30-1.91
2011-12-310.23
2012-03-31-3.46
2012-06-30-3.93
2012-09-30-5.33
2012-12-31-3.53
2013-03-31-2.24
2013-06-30-1.80
2013-09-30-2.35
2013-12-31-2.90
2014-03-31-5.88
2014-06-3035.96
2014-09-303.35
2014-12-3120.46
2015-03-31182.51
2015-06-3083.46
2015-09-3043.45
2015-12-3123.91
2016-03-3138.91
2016-06-3024.55
2016-09-304.95
2016-12-3121.91
2017-03-3138.12
2017-06-3031.35
2017-09-3031.98
2017-12-3137.40
2018-03-3122.39
2018-06-3025.27
2018-09-3022.88
2018-12-3116.76
2019-03-3125.45
2019-06-3013.31
2019-09-3012.49
2019-12-319.39
2020-03-3110.98
2020-06-309.00
2020-09-306.86
2020-12-3110.78
2021-03-3160.84
2021-06-3017.20
2021-09-3016.45
2021-12-31158.92
2022-03-3116.82
2022-06-3049.11
2022-09-30260.26
2022-12-3118.93
2023-03-3129.06
2023-06-30-492.89
2023-09-30-23.56
2023-12-31336.03
2024-03-313703.54
2024-06-3018.32
2024-09-3011.17
2024-12-3132.71
2025-03-31-38.67
2025-06-3019.62
2025-09-30-14.93
2025-12-31-173.57

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.